Although IRS-1 overexpression promotes tumorigenesis, IRS-1 is not required for primary tumor growth as demonstrated by the fact that mammary tumor initiation and growth are not prevented or delayed in Irs-1-/- mice in response to the PyV-MT antigen when compared with tumors that develop in wildtype littermates [79]. The gene discussed is IRS1; the disease is breast cancer.